Follow The Filings

MLTXMoonlake Immunotherapeutics

Q1 2024 13F holders among managers we track Latest ownership dossier

Ticker
MLTX
Type
Equity
Class
CLASS A ORD
Total reported value (long equity)
Manager Report date Value Shares